1. Introduction {#sec1}
===============

Neutropenia is characterized by a low neutrophil number, which could be a risk of disease development including infectious and cancerous diseases \[[@B1]--[@B6]\]. Thus, therapeutic approaches such as administration with G-CSF or GM-CSF have been applied to prevent neutropenic phenomenon, while no trials are completely worked yet \[[@B7]--[@B10]\]. Macrophages, one of the players in the innate immune system, modulate immune response through inflammatory cytokines and reactive oxygen species (ROS) \[[@B11]--[@B13]\]. In neutropenic situation, macrophages could not be involved in inflammation because neutrophil depletion results in no reaction of monocytes and macrophages \[[@B14]\]. As macrophages produce CSF, an activation of macrophages is crucial for preventing neutropenia and secondary diseases \[[@B15]--[@B17]\].

Extracts from deer bones, called nok-gol in Korean, have been traditionally used as a drug invigorating Qi. Recent researches further reported various therapeutic effects of this traditional medicine on inflammatory disease \[[@B18], [@B19]\], bone resorption \[[@B20]\], and aging \[[@B21]\]. Furthermore, extracts of deer bones affected macrophagic activation in *S*. *aureus*-infected mice \[[@B22]\]. In this study, we demonstrate that water extract of deer bones (hereafter, NG) alleviates neutropenia through activating macrophages.

2. Materials and Methods {#sec2}
========================

2.1. Cell Culture and Deer Bone Extract Preparation {#sec2.1}
---------------------------------------------------

Raw264.7 mouse monocytic/macrophagic cells were grown in Dulbecco\'s Modified Eagle\'s Medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS) and 1% antibiotics at 37°C in a 5% CO~2~ humidified incubator. Water extract of deer bones (NG) was provided by Nongshim Corporation (Republic of Korea). More information on NG production processes could be requested from the company.

2.2. **In Vivo** Studies {#sec2.2}
------------------------

Six-week-old male ICR mice were purchased from Orient (Sungnam, Republic of Korea). All procedures were performed on the approval of the animal care center of Kyung Hee University (Approval no. KHUASP (SE)-12-042). To induce neutropenia, mice were intraperitoneally injected with 150 mg/kg of cyclophosphamide twice in one week and then treated with cyclophosphamide (100 mg/kg) two times in another week. Mice were rested for one week with no treatment when treatments were switched. In addition, mice were randomized into 4 groups (normal, control, G-CSF, and NG; five mice per group) during resting time points. G-CSF (1 *μ*g/kg) or NG (200 mg/kg) was orally administered every day for the last procedure. At the end of the experiment, mice were sacrificed by CO~2~ inhalation, and cardiac blood was collected.

2.3. Cell Surface Observation {#sec2.3}
-----------------------------

Cells seeded into 60 mm culture dish at a density of 3 × 10^5^ cells/dish were treated with NG (25, 250, 500 *μ*g/mL) for 24 h. Cell surfaces were observed by taking images using a camera (Olympus, Japan) connected to a light microscope.

2.4. Cell Viability Assay {#sec2.4}
-------------------------

Cell viability was determined using WST assay (Dogen, Republic of Korea). RAW264.7 cells (1 × 10^4^ cells/well) were seeded into 96-well plates and incubated overnight. Cells were then treated with different concentrations of NG and incubated for another 24 hours. 10 *μ*L of WST solution was added to 100 *μ*L cell culture medium, and plates were incubated for 2 hours. Optical density (OD) was determined at 450 nm using a microplate reader (Versa Max, Molecular Devices, CA, USA).

2.5. Intracellular ROS Level Measurement {#sec2.5}
----------------------------------------

Raw264.7 cell pellets were washed with PBS and incubated with 20 *μ*M DCFH-DA for 1 hour at 37°C in the dark. After washing with PBS, green fluorescence (480 nm excitation/530 nm emission) was measured by flow cytometry (BD FACSCalibur).

2.6. Detection of Nitric Oxide (NO) {#sec2.6}
-----------------------------------

NO production was measured by adding Griess reagent in culture medium (Welgene, Republic of Korea). In detail, 150 *μ*L of supernatant from each well was transferred to 96-well plate and then mixed with 150 *μ*L of Griess reagent solution. Mixtures were then incubated for 30 min at room temperature. OD was determined at 570 nm using a microplate reader.

2.7. RT-PCR {#sec2.7}
-----------

Raw264.7 cell pellets were washed with ice-cold PBS, and RNAs were extracted using the easy-blue RNA extraction kit (Intron Biotech, Korea) according to the manufacturer\'s instructions. Total RNAs were quantified using NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies Inc.) and subjected to reverse transcriptions using cDNA synthesis kit (TaKaRa, Japan). Conventional PCRs were then performed using appropriate primers. GAPDH was used as an internal control. Primer information was described in [Table 1](#tab1){ref-type="table"}.

2.8. IL-6 and TNF-*α* Measurement {#sec2.8}
---------------------------------

IL-6 and TNF-*α* levels from Raw264.7 were measured by sandwich ELISA using BD Pharmingen mouse ELISA set. Cells in 6-well plates were treated with different concentrations of NG and incubated for 24 h. Cytokine levels were measured at 450 nm using a microplate reader.

2.9. Western Blot Analysis {#sec2.9}
--------------------------

Whole cell lysates were washed with ice-cold PBS and lysed with RIPA buffer. Equal amount of protein (30 *μ*g) was run on 10% SDS-PAGE and transferred to nitrocellulose membranes. Blotted membranes were then incubated overnight at 4°C with appropriate primary antibodies. After washing in PBS-tween 20 for 1 hour, membranes were incubated with appropriate HRP-conjugated secondary antibodies and bands were visualized with the enhanced chemiluminescence detection system (Amersham-Pharmacia Biotech, Buckinghamshire, UK).

2.10. Analyses of Cardiac Blood {#sec2.10}
-------------------------------

Whole blood samples from mice were collected by cardiac punctures. Blood was loaded in Vacutainer tubes containing EDTA (BD Biosciences, USA). Analyses of WBC, neutrophil, and monocyte in blood were done using blood analyzer (Hemavet 950, Drew Scientific, Germany).

2.11. Statistical Analysis {#sec2.11}
--------------------------

Data from experiments performed in triplicate presented mean ± standard deviation. Statistical significance was obtained by Student\'s *t*-test, and a *P* value less than 0.05 was considered statistically significant.

3. Results and Discussion {#sec3}
=========================

3.1. Water Extract of Deer Bone (NG) Induces RAW264.7 Cell Differentiation {#sec3.1}
--------------------------------------------------------------------------

LPS has been known to induce a differentiation of monocytic Raw264.7 cells to macrophages. Consistently, LPS (1 *μ*g/mL) induced Raw264.7 differentiation in our experiment. Likewise, NG treatment also resulted in Raw264.7 cell differentiation in a dose-dependent manner ([Figure 1(a)](#fig1){ref-type="fig"}). In addition, both LPS and NG increased WST activities in RAW264.7 cells, indicating that NG induced activities of dehydrogenases ([Figure 1(b)](#fig1){ref-type="fig"}). Macrophages secrete ROS, when being activated \[[@B23]\]. So, we further measured ROS levels in Raw264.7 cells treated with different concentrations of NG or LPS. As seen in [Figure 1(c)](#fig1){ref-type="fig"}, NG augmented ROS level in a dose-dependent manner. Thus, our data indicate that NG induces Raw264.7 cell differentiation to macrophages.

3.2. NG Increases NO Concentration and Induces Expression of iNOS and COX-2 {#sec3.2}
---------------------------------------------------------------------------

We next examined whether NG affects intracellular NO contents in Raw264.7 cells. When Raw264.7 cells were treated with different concentrations of NG or LPS as a positive control, both NG and LPS increased NO production ([Figure 2(a)](#fig2){ref-type="fig"}). As NO generation is associated with iNOS and COX-2, we further examined whether NG affects iNOS and COX-2. NG treatment increased expression of both iNOS and COX-2 (Figures [2(b)](#fig2){ref-type="fig"} and [2(c)](#fig2){ref-type="fig"}).

3.3. NG Produces IL-6 and TNF-*α* {#sec3.3}
---------------------------------

Macrophages react to microbial invasion through IL-6 and TNF-*α* secretion \[[@B17], [@B24]\]. Therefore, we measured the levels of IL-6 and TNF-*α* in Raw264.7 cells treated with different concentrations of NG for 24 hours. NG as well as LPS significantly increased levels of IL-6 and TNF-*α* (Figures [3(a)](#fig3){ref-type="fig"} and [3(b)](#fig3){ref-type="fig"}). This NG effect on IL-6 and TNF-*α* resulted from transcriptional regulation of both cytokines because NG treatment induced mRNA expression of either IL-6 or TNF-*α* ([Figure 3(c)](#fig3){ref-type="fig"}).

3.4. NG Induces Activation of MAPKs and NF-*κ*B {#sec3.4}
-----------------------------------------------

It has been reported that LPS activates macrophages through activation of MAPKs and NF-*κ*B \[[@B25]\]. So, we examined whether NG affects signaling pathways of MAPKs and NF-*κ*B in Raw264.7 cells. When Raw264.7 cells were treated with 250 *μ*g/mL of NG for 360 minutes, ERK phosphorylation was increased at 10 minutes after NG treatment and sustained until 30 minutes after NG treatment. JNK phosphorylation was increased at 10 minutes after NG treatment and peaked up at 30 minutes. However, NG appeared not to affect p38 phosphorylation ([Figure 4(a)](#fig4){ref-type="fig"}). We also found that NG activates NF-*κ*B pathway. IKK phosphorylation was gradually increased from 10 minutes and peaked up at 30 minutes after NG treatment. Likewise, I*κ*B phosphorylation was increased during that time points and total I*κ*B level was consistently reduced ([Figure 4(b)](#fig4){ref-type="fig"}). Accordingly, NG resulted in nuclear accumulation of phosphorylated form of NF-*κ*B, when phosphorylated form of NF-*κ*B in cytoplasmic and nuclear fractions were analyzed ([Figure 4(c)](#fig4){ref-type="fig"}). Thus, our data indicate that NG activates MAPK and NF-kB pathways as like LPS ([Figure 5](#fig5){ref-type="fig"}).

3.5. NG Alleviates in Mouse Neutropenia Model System {#sec3.5}
----------------------------------------------------

To verify NG effect in immune systems *in vivo*, we applied mouse neutropenia model system. In mice treated with NG, blood analyses presented a decrease of lymphocyte numbers and an increase of either neutrophils or eosinophils ([Table 2](#tab2){ref-type="table"}). In NG-treated mice compared to normal mice, lymphocyte numbers were diminished by approximately 30% and neutrophil numbers were increased by approximately 30%. While numbers of monocytes and basophils were not altered significantly, eosinophil numbers were also significantly increased from 2.79% to 4.68%. Thus, our *in vivo* data indicate that NG treatment may improve immune defects including neutropenia.

4. Conclusion {#sec4}
=============

Our purpose of the study is to know whether NG has an immunomodulating effect. We confirmed that NG treatment increased ROS and promoted macrophagic differentiation of mouse monocytic Raw264.7 cells. In the *in vivo* study, we confirmed that NG improved immune defects including neutropenia. Hence, we conclude that NG is helpful for alleviating neutropenia.
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![NG activates RAW264.7 cells. (a) Cells were seeded into 60 mm culture dish at a density of 3 × 10^5^ cells/dish. The next day, cells were treated with NG for 24 h. Cell surface was observed by taking a photograph using a camera attached to a microscope. (b) Cell viability was determined using WST assay after NG treatment. (c) ROS level was measured using DCFH-DA. Data are shown as the mean of three independent experiments (error bars are mean ± standard deviation (SD)) (\**P* \< 0.05, \*\**P* \< 0.01, and \*\*\**P* \< 0.001).](ECAM2013-617302.001){#fig1}

![NG augmented NO concentration and iNOS and COX-2 expression. (a) NO production was measured using Griess reagent. (b) iNOS and COX-2 mRNA expression was measured by RT-PCR. (c) iNOS and COX-2 protein expression was measured by Western blot. Data are shown as the mean of three independent experiments (error bars are mean ± standard deviation (SD)) (\**P* \< 0.05, \*\**P* \< 0.01, and \*\*\**P* \< 0.001).](ECAM2013-617302.002){#fig2}

![NG increased cytokines production. The release of IL-6 and TNF-*α* was measured by sandwich ELISA assay. Data are shown as the mean of three independent experiments (error bars are mean ± standard deviation (SD)) (\**P* \< 0.05, \*\**P* \< 0.01, and \*\*\**P* \< 0.001).](ECAM2013-617302.003){#fig3}

![NG induced activation of MAPK and NF-*κ*B. (a) Whole-cell lysates were analyzed by Western blot for the detection of specific proteins, as indicated (p-ERK, p-p38, p-JNK, and tubulin). (b)Whole-cell lysates were analyzed by Western blot for the detection of specific proteins, as indicated (IKK, p-IKK, I*κ*B*α*, p-I*κ*B*α*, and tubulin). (c) Nuclear and cytosolic extracts were analyzed by Western blot for the detection of specific proteins, as indicated (p-NF-*κ*B, tubulin, and lamin).](ECAM2013-617302.004){#fig4}

![NG induces immune responses through MAPKs and NF-*κ*B activation (schematic diagram).](ECAM2013-617302.005){#fig5}

###### 

The sequence of PCR primers.

  Primer name   Sequences
  ------------- -------------------------------------------
  IL-6           
   Forward      5′-CAA GAG ACT TCC ATC CAG TTG C-3′
   Reverse      5′-TTG CCG AGT TCT CAA AGT GAC-3′
  TNF-*α*        
   Forward      5′-ATG AGC ACA GAA AGC ATG ATC-3′
   Reverse      5′-TAC AGG CTT GTC ACT GGA ATT-3′
  COX-2          
   Forward      5′-AAG ACT TGC CAG GCT GAA CT-3′
   Reverse      5′-CTT CTG CAG TCC CAG GTT CAA-3′
  iNOS           
   Forward      5′-AAT GGC AAC ATC AGG TCG GCC ATC ACT-3′
   Reverse      5′-GCT GTG TGT CAC AGA AGT CTC GAA CTC-3′
  GAPDH          
   Forward      5′-GAG GGG CCA TCC ACA GTC TTC-3′
   Reverse      5′-CAT CAC CAT CTT CCA GGA GCG-3′

###### 

The number of WBC, lymphocytes, neutrophils, monocytes, and eosinophils in mice blood. Each value presents the mean ± SD (\**P* \< 0.05, \*\**P* \< 0.01, and \*\*\**P* \< 0.001).

###### 

\(a\)

  ---------------------------------------------------------------------------------
                     Normal         Negative Con        Positive Con   NG
  ------------------ -------------- ------------------- -------------- ------------
  WBC\               10.89 ± 1.57   2.49 ± 1.48\*\*\*   4.93\          5.10\
  (K/uL)                                                ± 0.71\*\*\*   ± 1.48\*\*

  Lymphocytes\       6.21\          0.76\               1.77\          2.00\
  (K/uL)             ± 1.27         ± 0.27\*\*\*        ± 0.39\*\*     ± 0.56\*\*

  Neutrophils\       2.81\          1.07\               2.75\          2.91\
  (K/uL)             ± 0.77         ± 0.72\*            ± 0.67         ± 0.79

  Monocytes (K/uL)   0.59\          0.18\               0.15\          0.12\
                     ± 0.16         ± 0.07\*\*          ± 0.07\*\*\*   ± 0.04\*\*

  Eosinophils\       0.22\          0.37\               0.38\          0.30\
  (K/uL)             ± 0.07         ± 0.06\*            ± 0.06\*       ± 0.13

  Basophils\         0.05\          0.04\               0.05\          0.07\
  (K/uL)             ± 0.02         ± 0.02              ± 0.02         ± 0.04
  ---------------------------------------------------------------------------------

###### 

\(b\)

  --------------------------------------------------------------------
                 Normal   Negative Con   Positive Con   NG
  -------------- -------- -------------- -------------- --------------
  Lymphocytes\   60.01\   41.93\         41.64\         31.05\
  (%)            ± 6.85   ± 9.20\*       ± 9.18\*       ± 7.25\*\*\*

  Neutrophils\   29.87\   35.15\         55.95\         60.31\
  (%)            ± 8.26   ± 19.12        ± 11.12\*\*    ± 7.88\*\*\*

  Monocytes\     5.59\    5.21\          6.77\          4.06\
  (%)            ± 0.64   ± 1.97         ± 1.62         ± 2.73

  Eosinophils\   2.79\    8.99\          7.12\          4.68\
  (%)            ± 1.33   ± 2.58\*\*     ± 2.04\*\*     ± 0.73\*

  Basophils\     0.50\    1.78\          1.54\          1.07\
  (%)            ± 0.10   ± 0.89\*       ± 0.23\*\*\*   ± 0.62
  --------------------------------------------------------------------
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